Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Trial of Neuroprotection With ACTH in Acute Optic Neuritis

NCT01838174 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01838174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01838174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Trial of Neuroprotection With ACTH in Acute Optic Neuritis
Lead sponsor
University of Colorado, Denver
Phase
Phase 4
Overall status
Terminated
Start date
May 31, 2013
Completion date
January 13, 2022
Enrollment
37 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis